Show simple item record

dc.contributor.authorChan, W. Y.
dc.contributor.authorCounsell, N.
dc.contributor.authorde Tute, R.
dc.contributor.authorDe-Silva, D.
dc.contributor.authorPhillips, Elizabeth H
dc.contributor.authorCavenagh, J.
dc.contributor.authorAdedayo, T.
dc.contributor.authorBraganca, N.
dc.contributor.authorRoddie, C.
dc.contributor.authorStreetly, M.
dc.contributor.authorSchey, S.
dc.contributor.authorKoh, M. B. C.
dc.contributor.authorCrowe, J.
dc.contributor.authorMorris, T. C.
dc.contributor.authorCook, G.
dc.contributor.authorClifton-Hadley, L.
dc.contributor.authorRabin, N.
dc.contributor.authorOwen, R. G.
dc.contributor.authorPopat, R.
dc.contributor.authorYong, K. L.
dc.date.accessioned2021-10-28T09:26:21Z
dc.date.available2021-10-28T09:26:21Z
dc.date.issued2021en
dc.identifier.citationChan WY, Counsell N, Tute R, De?Silva D, Phillips EH, Cavenagh J, et al. Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial. British Journal of Haematology. Wiley; 2021.en
dc.identifier.pmid34636043en
dc.identifier.doi10.1111/bjh.17903en
dc.identifier.urihttp://hdl.handle.net/10541/624743
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1111/bjh.17903en
dc.titleOutcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trialen
dc.typeOtheren
dc.contributor.departmentUniversity College London Hospitals NHS Foundation Trust, London, UKen
dc.identifier.journalBritish Journal of Haematologyen
dc.description.noteen]
refterms.dateFOA2021-11-03T09:31:10Z


Files in this item

Thumbnail
Name:
BJH.pdf
Size:
306.2Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record